PA
PBLS

Parallel Advisors’s Parabilis Medicines Inc PBLS Stock Holding History

Parallel Advisors’s Portfolio PBLS Stock Details PBLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Buy
+550
New +$15.2K ﹤0.01% 2758

Other funds holding PBLS

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
BIA
Bell Investment Advisors Oakland, California $681M AUM 18.36% 1-Year Est. Return

Parallel Advisors's PBLS Position: Q2 2026 in Review

Parallel Advisors opened a new position in Parabilis Medicines Inc (PBLS) in Q2 2026: 550 shares worth $15.1K. The stake represents ﹤0.01% of the portfolio and ranks #2758 among its holdings.

17 funds tracked by Wall St. Rank hold PBLS as of Q2 2026.

  • Parallel Advisors held 550 shares of Parabilis Medicines Inc worth $15.1K as of Q2 2026.
  • Parabilis Medicines Inc was a new Parallel Advisors position in Q2 2026.
  • Parabilis Medicines Inc made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2758 holding.
  • 17 funds tracked by Wall St. Rank held Parabilis Medicines Inc as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.